Factors conditioning P2Y12 inhibitor choice after an acute coronary syndrome

被引：0
|
作者：
Fernando Fonseca Goncalves, F. [1 ]
Borges, S. C. [1 ]
Monteiro, J. J. [1 ]
Mateus, P. S. [1 ]
Moreira, J. I. [1 ]
机构：
[1] Hosp Ctr Tras Os Montes & Alto Douro, Cardiol, Vila Real, Portugal
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2020年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1367
引用
收藏
页码：245 / 245
页数：1
相关论文
共 50 条
  • [1] Choice of P2Y12 Inhibitors After Acute Coronary Syndrome
    Ando, Giuseppe
    Gragnano, Felice
    Pelliccia, Francesco
    Calabro, Paolo
    AMERICAN JOURNAL OF CARDIOLOGY, 2024, 211 : 377 - 377
  • [2] P2Y12 inhibitor in acute coronary syndromes
    Wiwanitkit, Viroj
    NATIONAL MEDICAL JOURNAL OF INDIA, 2013, 26 (04): : 249 - 249
  • [3] Risk of cancer after an acute coronary syndrome according to the type of P2Y12 inhibitor
    Raposeiras-Roubin, Sergio
    Abu-Assi, Emad
    Munoz-Pousa, Isabel
    Cespon-Fernandez, Maria
    Cobas-Paz, Rafael
    Caneiro-Queija, Berenice
    Lopez-Rodriguez, Elena
    Perez-Casares, Luis
    Jamhour-Chelh, Karim
    Castineira-Busto, Maria
    Barreiro-Pardal, Cristina
    Calvo-Iglesias, Francisco
    Iniguez-Romo, Andres
    THROMBOSIS RESEARCH, 2019, 174 : 51 - 58
  • [4] Selection of P2Y12 Inhibitor in Percutaneous Coronary Intervention and/or Acute Coronary Syndrome
    Tantry, Udaya S.
    Navarese, Eliano P.
    Myat, Aung
    Gurbel, Paul A.
    PROGRESS IN CARDIOVASCULAR DISEASES, 2018, 60 (4-5) : 460 - 470
  • [5] P2Y12 inhibitor monotherapy after coronary stenting according to type of P2Y12 inhibitor
    Kim, Juwon
    Jang, Woo Jin
    Lee, Wang Soo
    Choi, Ki Hong
    Lee, Joo Myung
    Park, Taek Kyu
    Yang, Jeong Hoon
    Choi, Jin-Ho
    Bin Song, Young
    Choi, Seung-Hyuk
    Gwon, Hyeon-Cheol
    Lee, Sang Hoon
    Oh, Ju-Hyeon
    Chun, Woo Jung
    Park, Yong Hwan
    Im, Eul-Soon
    Jeong, Jin-Ok
    Cho, Byung Ryul
    Oh, Seok Kyu
    Yun, Kyeong Ho
    Cho, Deok-Kyu
    Lee, Jong-Young
    Koh, Young-Youp
    Bae, Jang-Whan
    Choi, Jae Woong
    Yoon, Hyuck Jun
    Lee, Seung Uk
    Cho, Jang Hyun
    Choi, Woong Gil
    Rha, Seung-Woon
    Hahn, Joo-Yong
    HEART, 2021, 107 (13) : 1077 - 1083
  • [6] P2Y12 Inhibitor Adherence Patterns in Patients with Acute Coronary Syndrome
    Ozaki, Aya
    Ko, Dennis T.
    Chong, Alice
    Fang, Jiming
    Austin, Peter
    Sud, Maneesh
    Jackevicius, Cynthia A.
    CIRCULATION, 2021, 144
  • [7] Ideal P2Y12 Inhibitor in Acute Coronary Syndrome: A Review and Current Status
    Pradhan, Akshyaya
    Tiwari, Aashish
    Caminiti, Giuseppe
    Salimei, Chiara
    Muscoli, Saverio
    Sethi, Rishi
    Perrone, Marco Alfonso
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (15)
  • [8] Reversible P2Y12 inhibitor versus irreversible P2Y12 inhibitor in ACS patients undergoing PCI (the acute coronary syndrome israeli survey (ACSIS)
    Eliaz, R.
    Mengesha, B.
    Ovdat, T.
    Iakobishvili, Z.
    Hasdai, D.
    Kheifets, M.
    Klempfner, R.
    Beigel, R.
    Kalmanovich, E.
    Alcalai, R.
    Levi, A.
    EUROPEAN HEART JOURNAL, 2021, 42 : 1414 - 1414
  • [9] The impact of in-hospital P2Y12 inhibitor switch in patients with acute coronary syndrome
    Gajanana, Deepakraj
    Weintraub, William S.
    Kolm, Paul
    Rogers, Toby
    Iantorno, Micaela
    Buchanan, Kyle D.
    Ben-Dor, Itsik
    Pichard, Augusto D.
    Satler, Lowell F.
    Thourani, Vinod H.
    Torguson, Rebecca
    Okubagzi, Petros G.
    Waksman, Ron
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2018, 19 (08) : 912 - 916
  • [10] What Are Optimal P2Y12 Inhibitor and Schedule of Administration in Patients With Acute Coronary Syndrome?
    Cohen, Michael V.
    Downey, James M.
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2020, 25 (02) : 121 - 130
12345